APA (7th ed.) Citation

OA, S., ME, N., Y, A., JT, B., E, C., R, F., . . . J, L. (2024). Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapy. Cell communication and signaling : CCS, 22(1), 251. https://doi.org/10.1186/s12964-024-01626-6

Chicago Style (17th ed.) Citation

OA, Sukocheva, et al. "Signaling Controversy and Future Therapeutical Perspectives of Targeting Sphingolipid Network in Cancer Immune Editing and Resistance to Tumor Necrosis Factor-α Immunotherapy." Cell Communication and Signaling : CCS 22, no. 1 (2024): 251. https://doi.org/10.1186/s12964-024-01626-6.

MLA (9th ed.) Citation

OA, Sukocheva, et al. "Signaling Controversy and Future Therapeutical Perspectives of Targeting Sphingolipid Network in Cancer Immune Editing and Resistance to Tumor Necrosis Factor-α Immunotherapy." Cell Communication and Signaling : CCS, vol. 22, no. 1, 2024, p. 251, https://doi.org/10.1186/s12964-024-01626-6.